Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy — IMPACT

Locally Advanced Breast Cancer (LABC) Clinical Trial

Official title:
A Pilot Study of Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) and Fluorothymidine Positron Emission Tomography (FLT PET) in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy

Status Completed

Clinical Trial Summary

The objective of this pilot study is to determine the effectiveness of Fluorothymidine Positron Emission Tomography (FLT PET) and Blood Oxygen Level Dependent Magnetic Resonance Imaging (BOLD MRI) in assessing tumour response to neoadjuvant chemotherapy (NA CT) in women with locally advanced breast cancer.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Breast Neoplasms
Locally Advanced Breast Cancer (LABC)

Clinical Trial Details

NCT number	NCT01240681
Study type	Interventional
Source	Ontario Clinical Oncology Group (OCOG)
Contact
Status	Completed
Phase	N/A
Start date	April 2011
Completion date	January 2015

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00286247` - Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer	Phase 2